BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

...stem cell therapies. Yozma Bio Science is a JV between Israeli VC Yozma Group and Mirae SCI Co. Ltd....
BioCentury | Aug 3, 2018
Company News

SCM Lifescience, Yozma in MOU to develop stem cell therapies

...Phase I/IIa trial. Yozma Bio Science is a JV between Israeli VC Yozma Group and Mirae SCI Co. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Sep 7, 2018
Financial News

SCM raises $35M series C for stem cells to treat inflammation

...stem cell therapies. Yozma Bio Science is a JV between Israeli VC Yozma Group and Mirae SCI Co. Ltd....
BioCentury | Aug 3, 2018
Company News

SCM Lifescience, Yozma in MOU to develop stem cell therapies

...Phase I/IIa trial. Yozma Bio Science is a JV between Israeli VC Yozma Group and Mirae SCI Co. Ltd....
Items per page:
1 - 2 of 2